Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SMARCA4/BRG1-deficient non-small cell lung cancer: clinical, imaging, pathological features, and follow-up results of 23 patients

1 Jan 2025

Abstract excerpt

Background: SMARCA4/BRG1-deficient non-small cell lung cancer (S/B-d NSCLC) is a rare subtype of non-small cell lung cancer (NSCLC). The aim of this study was to investigate the clinical, imaging, serum tumor marker, and pathological features of S/B-d NSCLC, particularly computed tomography (CT) and 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) scan features. Methods: Our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Chromatin Remodeling and Cancer
Share to Mechanisms of cancer metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39958212
DOI: 10.21037/tlcr-24-567

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SMARCA4/BRG1-deficient non-small cell lung cancer: clinical, imaging, pathological features, and follow-up results of 23 patientsPMID 39958212Read ↗

CT Imaging Spectrum of SMARCA4-Deficient Non-Small Cell Lung Cancer: A Descriptive Case Series of 32 PatientsSemantic proximity Read ↗

[Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].Semantic proximity Read ↗

[Annual therapeutic advances in advanced non-small cell lung cancer in 2024].Semantic proximity Read ↗

Clinical features and prognostic biomarkers of patients with the rare SMACRA4 gene mutation in non-small cell lung cancerSemantic proximity Read ↗

Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancerSemantic proximity Read ↗

SMARCA4-deficient thoracic malignancies with small cell lung cancer-like features: A clinicopathological and molecular study of a heterogeneous group.Semantic proximity Read ↗

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.Semantic proximity Read ↗

SMARCA4 alterations in non-small cell lung cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients.Semantic proximity Read ↗

[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].Semantic proximity Read ↗

[Research Progress on SMARCA4 Mutation Non-small Cell Lung Cancer].Semantic proximity Read ↗

Clinicopathologic features of KRAS G12C-mutated non-small cell lung carcinomas:insights from 279 retrospective cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.